日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies

CYP3A4抑制剂酮康唑和维拉帕米以及CYP3A4诱导剂利福平对福斯他替尼药代动力学参数的影响:体外和I期临床研究结果

Martin, Paul; Gillen, Michael; Millson, David; Oliver, Stuart; Brealey, Clive; Grossbard, Elliott B; Baluom, Muhammad; Lau, David; Sweeny, David; Mant, Tim; Craven, Kelli

Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen.

通过基于图像的表型筛选鉴定的 Aurora 激酶抑制剂 R763/AS703569 的临床前表征

McLaughlin John, Markovtsov Vadim, Li Hui, Wong Steve, Gelman Marina, Zhu Yanhong, Franci Christian, Lang D Wayne, Pali Erlina, Lasaga Joe, Low Caroline, Zhao Feifei, Chang Betty, Gururaja Tarikere L, Xu Weiduan, Baluom Muhammad, Sweeny David, Carroll David, Sran Arvinder, Thota Sambaiah, Parmer Manjeet, Romane Angela, Clemens George, Grossbard Elliott, Qu Kunbin, Jenkins Yonchu, Kinoshita Taisei, Taylor Vanessa, Holland Sacha J, Argade Ankush, Singh Rajinder, Pine Polly, Payan Donald G, Hitoshi Yasumichi